Phase III Study of PI-88 in Post-Resection Hepatocellular Carcinoma (PATHWAY) Full study details from FDA <a href="http://clinicaltrials.gov/ct2/show/NCT00568308?term=liver+pi-88&rank=1" target="_blank">http://clinicaltrials.gov/ct2/show/NCT00568308?term=liver+pi-88&rank=1</a>